Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Allen

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Oncoimmunology|August 16, 2019
Daratumumab-<sup>225</sup>Actinium conjugate demonstrates greatly enhanced antitumor activity against experimental multiple myeloma tumorsWojciech Dawicki, Kevin J H Allen, Rubin Jiao, et al.
ACS Omega|July 29, 2025
Correction to "In Vitro and In Vivo Comparison of Random versus Site-Specific Conjugation of Bifunctional Chelating Agents to the CD33-Binding Antibody for Use in Alpha- and Beta-Radioimmunotherapy"Kevin J H Allen, Connor Frank, Rubin Jiao, et al.
AJNR. American Journal of Neuroradiology|March 1, 1985
Dyke Award. Evaluation of contrast-enhanced MR imaging in a brain-abscess modelV M Runge, J A Clanton, A C Price, et al.
ACS Omega|December 23, 2024
In Vitro and In Vivo Comparison of Random versus Site-Specific Conjugation of Bifunctional Chelating Agents to the CD33-Binding Antibody for Use in Alpha- and Beta-RadioimmunotherapyKevin J H Allen, Connor Frank, Rubin Jiao, et al.
Cancers|August 12, 2023
A Theranostic Approach to Imaging and Treating Melanoma with <sup>203</sup>Pb/<sup>212</sup>Pb-Labeled Antibody Targeting MelaninRubin Jiao, Kevin J H Allen, Mackenzie E Malo, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 25, 2022
An HPLC-UV validated bioanalytical method for measurement of <i>in vitro</i> phase 1 kinetics of α-synuclein binding bifunctional compoundsOmozojie P Aigbogun, Chukwunonso K Nwabufo, Madeline N Owens, et al.
Inorganic Chemistry|October 30, 2012
Lanthanide complexes of the Kläui metalloligand, CpCo(P═O(OR)2)3: an examination of ligand exchange kinetics between isotopomers by electrospray mass spectrometryKevin J H Allen, Emma C Nicholls-Allison, Kevin R D Johnson, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 30, 2021
Employing <i>in vitro</i> metabolism to guide design of F-labelled PET probes of novel α-synuclein binding bifunctional compoundsChukwunonso K Nwabufo, Omozojie P Aigbogun, Kevin J H Allen, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2022
Radioimmunotherapy Targeting IGF2R on Canine-Patient-Derived Osteosarcoma Tumors in Mice and Radiation Dosimetry in Canine and Pediatric ModelsJaline Broqueza, Chandra B Prabaharan, Kevin J H Allen, et al.
Nuclear Medicine and Biology|March 1, 2020
Comparison of various radioactive payloads for a human monoclonal antibody to glycoprotein 41 for elimination of HIV-infected cellsRavendra Garg, Kienna Mills, Kevin J H Allen, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Oncoimmunology|August 16, 2019
Daratumumab-<sup>225</sup>Actinium conjugate demonstrates greatly enhanced antitumor activity against experimental multiple myeloma tumorsWojciech Dawicki, Kevin J H Allen, Rubin Jiao, et al.
ACS Omega|July 29, 2025
Correction to "In Vitro and In Vivo Comparison of Random versus Site-Specific Conjugation of Bifunctional Chelating Agents to the CD33-Binding Antibody for Use in Alpha- and Beta-Radioimmunotherapy"Kevin J H Allen, Connor Frank, Rubin Jiao, et al.
AJNR. American Journal of Neuroradiology|March 1, 1985
Dyke Award. Evaluation of contrast-enhanced MR imaging in a brain-abscess modelV M Runge, J A Clanton, A C Price, et al.
ACS Omega|December 23, 2024
In Vitro and In Vivo Comparison of Random versus Site-Specific Conjugation of Bifunctional Chelating Agents to the CD33-Binding Antibody for Use in Alpha- and Beta-RadioimmunotherapyKevin J H Allen, Connor Frank, Rubin Jiao, et al.
Cancers|August 12, 2023
A Theranostic Approach to Imaging and Treating Melanoma with <sup>203</sup>Pb/<sup>212</sup>Pb-Labeled Antibody Targeting MelaninRubin Jiao, Kevin J H Allen, Mackenzie E Malo, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 25, 2022
An HPLC-UV validated bioanalytical method for measurement of <i>in vitro</i> phase 1 kinetics of α-synuclein binding bifunctional compoundsOmozojie P Aigbogun, Chukwunonso K Nwabufo, Madeline N Owens, et al.
Inorganic Chemistry|October 30, 2012
Lanthanide complexes of the Kläui metalloligand, CpCo(P═O(OR)2)3: an examination of ligand exchange kinetics between isotopomers by electrospray mass spectrometryKevin J H Allen, Emma C Nicholls-Allison, Kevin R D Johnson, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 30, 2021
Employing <i>in vitro</i> metabolism to guide design of F-labelled PET probes of novel α-synuclein binding bifunctional compoundsChukwunonso K Nwabufo, Omozojie P Aigbogun, Kevin J H Allen, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2022
Radioimmunotherapy Targeting IGF2R on Canine-Patient-Derived Osteosarcoma Tumors in Mice and Radiation Dosimetry in Canine and Pediatric ModelsJaline Broqueza, Chandra B Prabaharan, Kevin J H Allen, et al.
Nuclear Medicine and Biology|March 1, 2020
Comparison of various radioactive payloads for a human monoclonal antibody to glycoprotein 41 for elimination of HIV-infected cellsRavendra Garg, Kienna Mills, Kevin J H Allen, et al.
Pageof 11